NCT01151384 - Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions

Solid Tumors

Interventions

DRUG

LE-DT

Intravenous infusion, Upto 5 dose levels have been studied i.e. 50, 65, 85, 110 and 132 mg/m2, Every 3 weeks

Trial Locations (2)

Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.

TGEN/Scottsdale Clinical Research Institute, Scottsdale